相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。WIP1 dephosphorylation of p27Kip1 Serine 140 destabilizes p27Kip1 and reverses anti-proliferative effects of ATM phosphorylation
Byung-Kwon Choi et al.
CELL CYCLE (2020)
Potentiality of Protein phosphatase Mg2+/Mn2+ dependent 1D as a biomarker for predicting prognosis in acute myeloid leukemia patients
Meijia Yu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
PPM1D Functions as Oncogene and is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma
Ke Li et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity
Malgorzata Krzesniak et al.
CELLULAR SIGNALLING (2020)
Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells
Roberta Napolitano et al.
ONCOLOGY REPORTS (2020)
WIP1 Contributes to the Adaptation of Fanconi Anemia Cells to DNA Damage as Determined by the Regulatory Network of the Fanconi Anemia and Checkpoint Recovery Pathways
Alfredo Rodriguez et al.
FRONTIERS IN GENETICS (2019)
Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy
Borahm Kim et al.
PLOS ONE (2019)
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery
Giorgia Simonetti et al.
CANCER (2019)
PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells
Josephine D. Kahn et al.
BLOOD (2018)
ATR kinase regulates its attenuation via PPM1D phosphatase recruitment to chromatin during recovery from DNA replication stress signalling
Debadrita Bhattacharya et al.
JOURNAL OF BIOSCIENCES (2018)
The Cellular p53 Inhibitor MDM2 and the Growth Factor Receptor FLT3 as Biomarkers for Treatment Responses to the MDM2-Inhibitor Idasanutlin and the MEK1 Inhibitor Cobimetinib in Acute Myeloid Leukemia
Katja Seipel et al.
CANCERS (2018)
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
Joanne Hsu et al.
CELL STEM CELL (2018)
Safety, Efficacy, Pharmacokinetic (PK) and Biomarker Analyses of BCL2 Inhibitor Venetoclax (Ven) Plus MDM2 Inhibitor Idasanutlin (idasa) in Patients (pts) with Relapsed or Refractory (R/R) AML: A Phase Ib, Non-Randomized, Open-Label Study
Naval G. Daver et al.
BLOOD (2018)
Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma
Chiao-En Wu et al.
BRITISH JOURNAL OF CANCER (2018)
Wild-type p53-induced phosphatase 1 is a prognostic marker and therapeutic target in bladder transitional cell carcinoma
Zhi-Peng Wang et al.
ONCOLOGY LETTERS (2017)
Census and evaluation of p53 target genes
M. Fischer
ONCOGENE (2017)
DNA damage-induced phosphatase Wip1 in regulation of hematopoiesis, immune system and inflammation
B. Uyanik et al.
CELL DEATH DISCOVERY (2017)
Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy
Miron Prokocimer et al.
BLOOD (2017)
ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration
Himjyot Jaiswal et al.
EMBO JOURNAL (2017)
Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts
Bernhard Reis et al.
HAEMATOLOGICA (2016)
Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models
Christian Lehmann et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Chemical Inhibition of Wild-Type p53-Induced Phosphatase 1 (WIP1/PPM1D) by GSK2830371 Potentiates the Sensitivity to MDM2 Inhibitors in a p53-Dependent Manner
Arman Esfandiari et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy
V. Clausse et al.
CELL DEATH & DISEASE (2016)
Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3
Sona Pechackova et al.
ONCOTARGET (2016)
Wip1 phosphatase: between p53 and MAPK kinases pathways
Anastasia R. Goloudina et al.
ONCOTARGET (2016)
Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts
Bernhard Reis et al.
HAEMATOLOGICA (2016)
Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma
Elizabeth M. Swisher et al.
JAMA ONCOLOGY (2016)
PPM1D controls nucleolar formation by up-regulating phosphorylation of nucleophosmin
Yuuki Kozakai et al.
SCIENTIFIC REPORTS (2016)
Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients
A. Zajkowicz et al.
BRITISH JOURNAL OF CANCER (2015)
DNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase
Jan Brazina et al.
CELL CYCLE (2015)
Prognostic and predictive immune gene signatures in breast cancer
Davide Bedognetti et al.
CURRENT OPINION IN ONCOLOGY (2015)
PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38
M. Zhang et al.
ONCOGENE (2015)
Cytoplasmic nucleophosmin has elevated T199 phosphorylation upon which G2/M phase progression is dependent
Narisa Chan et al.
SCIENTIFIC REPORTS (2015)
Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo
T. J. Phesse et al.
CELL DEATH AND DIFFERENTIATION (2014)
Prognostic value of PPM1D in 800 gastric cancer patients
Dan Ma et al.
MOLECULAR MEDICINE REPORTS (2014)
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie et al.
NATURE MEDICINE (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
PPM1D is a prognostic marker and therapeutic target in colorectal cancer
Tian-Shu Peng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Downregulation of Wip1 phosphatase modulates the cellular threshold of DNA damage signaling in mitosis
Libor Macurek et al.
CELL CYCLE (2013)
Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint
Petra Kleiblova et al.
JOURNAL OF CELL BIOLOGY (2013)
Protein Phosphatase Magnesium-Dependent 1δ (PPM1D) mRNA Expression Is a Prognosis Marker for Hepatocellular Carcinoma
Guang-Bing Li et al.
PLOS ONE (2013)
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
Frank G. Rueckner et al.
BLOOD (2012)
MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63
L. D. Gamble et al.
ONCOGENE (2012)
Wip1 Directly Dephosphorylates Y-H2AX and Attenuates the DNA Damage Response
Hyukjin Cha et al.
CANCER RESEARCH (2010)
Mechanism of p53 stabilization by ATM after DNA damage
Qian Cheng et al.
CELL CYCLE (2010)
Phosphorylation and Degradation of MdmX Is Inhibited by Wip1 Phosphatase in the DNA Damage Response
Xinna Zhang et al.
CANCER RESEARCH (2009)
Wip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression
Arne Lindqvist et al.
EMBO JOURNAL (2009)
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling
Roel G. W. Verhaak et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase
Alexander Kohlmann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
The Wip1 phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop
Xiongbin Lu et al.
CANCER CELL (2007)
Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers
Eunsil Yu et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias
L-I Lin et al.
LEUKEMIA (2006)
Wip1 phosphatase modulates ATM-dependent signaling pathways
Sathyavageeswaran Shreeram et al.
MOLECULAR CELL (2006)
MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy
K Kojima et al.
BLOOD (2005)
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints
XB Lu et al.
GENES & DEVELOPMENT (2005)
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia:: association with FAB subtypes and identification of subgroups with poor prognosis
C Thiede et al.
BLOOD (2002)
分享论文
